Eg5/KSP is a homotetrameric, Kinesin-5 family member whose ability to cross-link microtubules has associated it with mitotic spindle assembly and dynamics for chromosome segregation. Transient-state kinetic methodologies have been used to dissect the mechanochemical cycle of a dimeric motor, Eg5-513, to better understand the cooperative interactions that modulate processive stepping. Microtubule association, ADP release, and ATP binding are all fast steps in the pathway. However, the acidquench analysis of the kinetics of ATP hydrolysis with substrate in excess of motor was unable to resolve a burst of product formation during the first turnover event. In addition, the kinetics of P i release and ATP-promoted microtubule-Eg5 dissociation were observed to be no faster than the rate of ATP hydrolysis. In combination the data suggest that dimeric Eg5 is the first kinesin motor identified to have a rate-limiting ATP hydrolysis step. Furthermore, several lines of evidence implicate alternating-site catalysis as the molecular mechanism underlying dimeric Eg5 processivity. Both mantATP binding and mantADP release transients are biphasic. Analysis of ATP hydrolysis through single turnover assays indicates a surprising substrate concentration dependence, where the observed rate is reduced by half when substrate concentration is sufficiently high to require both motor domains of the dimer to participate in the reaction.Eg5 is a member of the homotetrameric, Bim C/Kinesin-5 family. Members of this family function during mitosis and provide a plus-end directed force that has become associated with bipolar spindle assembly, spindle maintenance, and microtubule (MT) 2 flux (1-10). The function of Eg5 in the mitotic spindle has been shown to be indispensable. Perturbation of its function prior to anaphase B by either antibody (1, 11) or small molecule inhibitors (12-23) causes collapse of the bipolar spindle into a monoaster and leads to apoptosis in cells with intact spindle checkpoint machinery (24, 25). As a result Eg5 has garnered substantial interest as a potential chemotherapeutic target in cancer treatment.Mechanistically, the ATPase cycle of monomeric Eg5 motor domains are fairly well understood both free in solution and bound to . Off the MT, monomeric Eg5 demonstrates weak ATP binding and has a propensity to form a nonproductive Eg5⅐ATP complex (31). However, on the MT, ATP binding is tight, substrate productively proceeds through ATP hydrolysis, and the rates of all the individual steps in the mechanochemical cycle are accelerated (30). The MT-activated ATPase cycle concludes with a conformational change of the motor domain in relation to the MT, termed "rolling" (29), followed by the rate-limiting event in the cycle, the coupled action of phosphate (P i ) release, and motor detachment from the MT (29,30,33).In vivo the individual Eg5 motor domains probably do not function independently; therefore, analysis of a higher order oligomeric structure is necessitated. Indeed, previous analysis of dimeric Eg5, Eg5-513, has...